Refining the approach to renal artery revascularization

Area of Science:

• Nephrology
• Vascular Medicine
• Cardiology

Background:

• Renal artery stenosis (RAS) encompasses diverse etiologies, including fibromuscular dysplasia (FMD) and atherosclerotic RAS (ARAS).
• Current classifications like renovascular hypertension and ischemic nephropathy are potentially misleading due to unproven causality.
• Limited evidence supports renal revascularization due to heterogeneity in causes, unclear RAS-nephropathy links, and inconsistent trial methodologies.

Purpose of the Study:

• To improve understanding of renal artery stenosis (RAS) epidemiology, clinical presentation, and diagnostic markers.
• To clarify the relationship between RAS and associated disease states, distinguishing renal ischemia from nephropathy.
• To review optimal revascularization techniques and strategies for preventing renal injury.

Main Methods:

• Literature review focusing on epidemiology, pathophysiology, and clinical aspects of RAS.
• Analysis of diagnostic criteria and clinical markers for RAS detection.
• Evaluation of evidence for renal revascularization outcomes and techniques.

Main Results:

• RAS is a heterogeneous condition with varied pathophysiology and clinical impact.
• Distinguishing true renal ischemia from nephropathy in RAS patients remains challenging.
• Optimal revascularization strategies and outcome assessment require further research and standardization.

Conclusions:

• Enhanced understanding of RAS epidemiology and diagnosis is essential for patient management.
• Clarifying the relationship between RAS, hypertension, and renal dysfunction is critical.
• Standardized approaches to revascularization and outcome evaluation are needed to improve patient care and research efficacy.